MGFZX
Price
$9.45
Change
-$0.01 (-0.11%)
Updated
May 9 closing price
Net Assets
151.04M
RNPEX
Price
$62.30
Change
+$0.12 (+0.19%)
Updated
May 9 closing price
Net Assets
142.07B
Ad is loading...

MGFZX vs RNPEX

Header iconMGFZX vs RNPEX Comparison
Open Charts MGFZX vs RNPEXBanner chart's image
MassMutual Global I
Price$9.45
Change-$0.01 (-0.11%)
VolumeN/A
Net Assets151.04M
American Funds New Perspective R4
Price$62.30
Change+$0.12 (+0.19%)
VolumeN/A
Net Assets142.07B
MGFZX vs RNPEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MGFZX vs. RNPEX commentary
May 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGFZX is a Buy and RNPEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RNPEX has more cash in the bank: 142B vs. MGFZX (151M). RNPEX pays higher dividends than MGFZX: RNPEX (0.55) vs MGFZX (0.00). MGFZX was incepted earlier than RNPEX: MGFZX (11 years) vs RNPEX (23 years). MGFZX (0.93) is less costly to investors than RNPEX (0.76). RNPEX is a more actively managed with annual turnover of: 24.00 vs. MGFZX (10.00). MGFZX has a lower initial minimum investment than RNPEX: MGFZX (0) vs RNPEX (250). RNPEX annual gain was more profitable for investors over the last year : 5.27 vs. MGFZX (-12.08). RNPEX return over 5 years is better than : 46.39 vs. MGFZX (-23.34).
MGFZXRNPEXMGFZX / RNPEX
Total Expense Ratio0.930.76122%
Annual Report Gross Expense Ratio0.930.76122%
Fund Existence11 years23 years-
Gain YTD-3.2722.282-143%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets151M142B0%
Annual Yield % from dividends0.000.55-
Returns for 1 year-12.085.27-229%
Returns for 3 years-22.2027.41-81%
Returns for 5 years-23.3446.39-50%
Returns for 10 years-36.2464.04-57%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALZN0.660.12
+21.87%
Alzamend Neuro Inc.
REPL7.71-0.06
-0.77%
Replimune Group
ASGN55.69-0.73
-1.29%
ASGN
TOI2.80-0.12
-4.11%
Oncology Institute (The)
AFRM46.41-7.85
-14.47%
Affirm Holdings